Abstract
Persistence with initial antidiabetic treatment regimens is critical for reducing the risk of adverse clinical events and costs. This study estimated the impact of persistence on clinical and cost outcomes among patients with type 2 diabetes (T2D).
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
Paper Title
Journal
Date
